Intravenous Iron: biomarkers and treatment strategies in anaemic Colorectal cancer patients. - Intravenous Iron: measuring response in anaemic surgical patients

Phase 1

• Conditions: Anaemia (specifically related to surgical pathology)

• Registration Number: EUCTR2009-011382-80-GB
• Lead Sponsor: ottingham University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-05-08
• Study Completion: 2012-03-20
• Last Update Posted: 25 November 2019

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

Age >18yrs
Diagnosis of Colorectal Cancer and a defined surgical operation date
Biochemically detectable anaemia.
Women of child bearing potential (who have a negative pregnancy
test) must agree to use methods of medically acceptable forms of contraception during the study; (e.g. intra-uterine device (IUD) or a double-barrier method of oral contraception with condom)

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Patients with a recognised allergy to intravenous iron, or related products.
A concurrent medical condition(s) that,in the view of the investigator, would prevent compliance or participation or jeopardize the health of the patients.

Any of the following groups:
Children; those unable to consent for themselves; pregnant females; prisoners

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified